Angiotensin II, a potent vasoconstrictor and known growth factor for vascular smooth muscle cells, has been implicated in the development of glomerulosclerosis. Because mesangial cell growth plays a critical role in the glomerulosclerotic process, the objective of this study was to determine the direct effect of long-term (48-hour) angiotensin II treatment on the growth of cultured murine mesangial cells. Subconfluent, quiescent adult murine mesangial cells were treated for 48 hours with media containing angiotensin II with and without its specific inhibitor losartan. There was a 7% increase in size in angiotensin II-treated cells and an 18% increase in size in serum plus insulin-treated cells, as demonstrated by fluorescence-activated cell sorting. Cells treated with serum-free medium plus insulin also showed significant increases in tritiated leucine incorporation and total protein content, but there was also an increase in tritiated thymidine incorporation without an increase in cell number. The addition of angiotensin II to insulin did not potentiate the effect of insulin. These results indicate that long-term angiotensin II administration caused hypertrophy without hyperplasia in quiescent, subconfluent cultured adult murine mesangial cells. Blockade of the subtype 1 angiotensin II receptor with losartan partially blocked the hypertrophic effect of angiotensin II. Insulin alone was also a hypertrophic factor for mesangial cells and, in addition, stimulated DNA synthesis. The effects of angiotensin II and insulin were not additive. (Hypertension 1993;21:29-35) KEY WORDS • glomerular mesangium • angiotensin II • hypertrophy G lomerulosclerosis is characterized morphologically by expansion of the mesangium, which is due to mesangial cell hypertrophy and matrix accumulation.
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Angiotensin II, a potent vasoconstrictor and known growth factor for vascular smooth muscle cells, has been implicated in the development of glomerulosclerosis. Because mesangial cell growth plays a critical role in the glomerulosclerotic process, the objective of this study was to determine the direct effect of long-term (48-hour) angiotensin II treatment on the growth of cultured murine mesangial cells. Subconfluent, quiescent adult murine mesangial cells were treated for 48 hours with media containing angiotensin II with and without its specific inhibitor losartan. In comparison to cells treated with serum-free medium, cells treated with serum plus insulin demonstrated a significant increase in cell number (1. ]leucine incorporation and 84% of the angiotensin II-induced increase in total protein content. There was a 7% increase in size in angiotensin II-treated cells and an 18% increase in size in serum plus insulin-treated cells, as demonstrated by fluorescence-activated cell sorting. Cells treated with serum-free medium plus insulin also showed significant increases in tritiated leucine incorporation and total protein content, but there was also an increase in tritiated thymidine incorporation without an increase in cell number. The addition of angiotensin II to insulin did not potentiate the effect of insulin. These results indicate that long-term angiotensin II administration caused hypertrophy without hyperplasia in quiescent, subconfluent cultured adult murine mesangial cells. Blockade of the subtype 1 angiotensin II receptor with losartan partially blocked the hypertrophic effect of angiotensin II. Insulin alone was also a hypertrophic factor for mesangial cells and, in addition, stimulated DNA synthesis. or puromycin toxicity model, 5 administration of angiotensin converting enzyme inhibitors has been shown to prevent or retard the development of mesangial cell hypertrophy and increased matrix deposition. This occurs regardless of whether or not increased intraglomerular pressure is present 3 and, thus, raises the possibility that, apart from its hemodynamic action to induce glomerulosclerosis, Ang II may have direct effects on the mesangial cell. Previous studies have shown that Ang II does not increase [ 3 H]thymidine incorporation in adult rat mesangial cells 6 but does have a mitogenic effect on human fetal mesangial cells 7 and SV-40 transformed murine mesangial cells. 8 Some of these studies are confusing because growth was assessed by only one parameter, i.e., cell number, [ 3 H]thymidine incorporation, or assessment of protein synthesis. Therefore, the purpose of this investigation was to use several different parameters of cell growth to determine whether long-term (48-hour) Ang II administration causes hypertrophy or hyperplasia in the mesangial cell in vitro. In addition, because insulin has been shown to be a progression factor for mesangial cells, 9 we investigated the combined effect of insulin and Ang II on growth in our cultured cell system. 
Murine Mesangial Cells
Adult Swiss Webster mice (Simonson, Gilroy, Calif.) were killed by cervical dislocation. With the use of sterile techniques, kidneys were removed, capsules stripped off, and cortex separated from medulla. Cortical fragments were chopped fine with scissors and washed well in sterile phosphate buffered saline (PBS). Washed fragments were then incubated with 1 mg/ml (final concentration) collagenase at 37°C for 45 minutes, with gentle pipetting at frequent intervals. The resulting fragments were sedimented at room temperature in sterile PBS to obtain glomerular cores and other fragments. The resulting mixture was passed through progressively smaller nylon screens (Tetko, Monterey Park, Calif.) to screen out unwanted larger fragments and were then sedimented through PBS five times to remove lighter tubular fragments. This resulted in a preparation that was approximately 80% pure glomerular cores.
Glomerular cores were plated out in RPMI 1640 and 25 mM HEPES, supplemented with 20% fetal bovine serum (Gemini Bioproducts, Calabasas, Calif.), 25 ^tg/ml recombinant human insulin, 100 IU/ml penicillin, and 100 fig/ml streptomycin. Cultures were maintained in a humidified environment of 5% CO2-95% air at 37°C and were fed three times a week. After approximately 2 weeks, when cells were nearly confluent, trypsin/EDTA was used to detach cells; they were then replated at a ratio of 1:3. Thereafter, cells were subcultured at weekly intervals when nearly confluent and used after the fourth subculture (>21 days). Cells were identified as mesangial cells using immunohistochemical and electron microscopic data. Study procedures were approved by the Institutional Animal Care and Use Committee of the University of Southern California.
Immunohistochemistry and Electron Microscopic Studies
Cells were grown on sterile coverslips and fixed with 10% neutral buffered formalin. After washing, cells were incubated in 1% H 2 O 2 /70% methanol to quench endogenous peroxidase, blocked with 10% normal goat serum (Zymed Labs, Inc., South San Francisco, Calif.), and incubated with polyclonal antibodies against either cytokeratin (1:800, Dako, Carpinteria, Calif.), myosin (1:400, Sigma), a-smooth muscle actin (1:1,000, Sigma), desmin (1:300, Chemicon International, Inc., Temecula, Calif.), or Factor VIII (1:200, Synbiotics, San Diego, Calif.). After washing, biotinylated goat antirabbit antibody, streptavidin-peroxidase, and aminoethyl carbazole (Zymed) were applied to visualize cellular antigens. For transmission electron microscopy, cells were fixed with Karnovsky's fixative, postfixed with 1% osmium tetroxide, dehydrated through a graded series of alcohols, and embedded in epoxy resin. One-micron-thick sections, stained with toluidine blue, were used for orientation. Thin sections, cut on an LKB ultramicrotome (Pharmacia LKB Biotechnology, Piscataway, N.J.), were stained with uranyl citrate and lead citrate and examined with a model 301 electron microscope (Philips Electronic Instruments Co., Mahwah, N.J.).
MTT Assay
Mesangial cells were plated into 6-cm dishes at different cell densities. Cells were treated with RPMI 1640 and 25 mM HEPES with 0.25% bovine serum albumin (serum-free medium) for 3 days, then treated with either 20% fetal calf serum plus 25 /ig/ml insulin or serum-free medium only for an additional 48 hours, with a medium change at 24 hours. An MTT assay was performed as previously described 10 in triplicate with ODyro read on a DU series 600 spectrophotometer (Beckman Instruments, Inc., Fullerton, Calif.). Matching triplicate dishes were trypsinized and counted using a model Zp Coulter counter (Hialeah, Fla.).
Assay of Angiotensins in Mesangial Cell Media
To confirm the persistence of Ang II in serum-free medium, 6-cm dishes of cells at a concentration of approximately 5 x 10 s cells per dish were incubated with 2 ml serum-free medium plus Ang II (10~6 M). Samples of medium were taken for assay at 0,30,60,120, and 240 minutes. Angiotensins were assayed by a previously described 11 combination of high-performance liquid chromatography and radioimmunoassay.
Cellular Growth Studies
Mesangial cells were subcultured into 6-cm dishes at a subconfluent density of 1-5 xlO 5 cells per dish. After 18 hours, cells were placed in serum-free medium for 72 hours to render them quiescent. After that time, cells were placed in experimental medium for 48 hours, with a change of medium at 24 hours. Experimental media were 1) serum-free medium alone, 2) standard growth medium (with serum and insulin), 3) serum-free medium with Ang II (10~3 to 10"* M), 4) serum-free medium with Ang II (10~6 M) and losartan (10"* M), 5) serum-free medium with insulin alone (10"* to 10"' M), and 6) serum-free medium with insulin (10~6 M) and Ang II (10"' M). After 48 hours in experimental media, cellular growth studies were conducted. All studies were performed in quadruplicate.
Cell counts were performed by trypsinizing cells and counting them on a Coulter counter. The threshold setting was 3 fim, and the probe aperture was set at 100 fim.
Tritiated thymidine incorporation was performed by incubating cells with 2 ml fresh serum-free medium (with appropriate additives) plus 2 jiCi methyl-[ 3 H]thymidine for 6 hours at 37°C. Dishes were then washed once with ice-cold PBS, then ice-cold 5% trichloroacetic acid. Dishes were then incubated for 15 minutes at 4°C and washed twice with ice-cold 5% trichloroacetic acid. Material was solubilized with 0.25% NaOH plus 1% sodium dodecyl sulfate at room temperature for 15 minutes. Dishes were scraped with a spatula, the resulting mixture was neutralized with HO, and an aliquot was placed in scintillation fluid (Cytoscint, ICN Pharmaceuticals, Irvine, Calif.) and counted in a liquid scintillation counter (Searle Delta 300, Des Plaines, 111.). Results were expressed as counts per minute per 10 5 cells.
Tritiated leucine incorporation was performed by incubating cells for 18 hours in leucine-free DMEM (with appropriate additives). The next morning, the medium was changed to leucine-poor DMEM (with appropriate additives) plus 2 ^Ci L- [4, H(AQ]leucine for 6 hours at 37°C. Dishes were then washed once with ice-cold PBS, then ice-cold 5% trichloroacetic acid, incubated for 15 minutes on ice, and then washed twice with ice-cold 5% trichloroacetic acid. Material was solubilized with 0.25% NaOH plus 1% sodium dodecyl sulfate at room temperature for 15 minutes. Dishes were scraped with a spatula, the resulting mixture was neutralized with HC1, and an aliquot was placed in scintillation fluid and counted in a scintillation counter. Results were expressed as counts per minute per 10 5 cells.
Total protein content was performed in quadruplicate by washing cells well with PBS then lysing the cells in situ with 1 ml ice-cold sterile water for 15 minutes at 4°C. After the lysis procedure was repeated, the resulting tysate was spun down and assayed for protein using the Peterson modification of the Lowry technique 12 (kit from Sigma). OD 750 was read on a Beckman DU series 600 spectrophotometer.
Determination of Cell Size
Cell size was determined by trypsinizing cells and suspending them in serum-free medium. Cell sorting 13 was used immediately thereafter to determine the cell size (Facstar Plus, Beckton Dickinson).
Statistical Analysis
All measurements were made in quadruplicate. Data are expressed as mean±SEM, and differences between groups were analyzed using analysis of variance on the CLINFO system. Statistical significance was defined at a value of p<0.05.
Results

Identification of Mesangial Cells
Cells were identified as mesangial cells by immunostaining with cell marker antibodies, as well as by examining their morphology under transmission electron microscopy. The cells stained positively for desmin and myosin and negatively for Factor VIII. Although some cells stained positively for keratin, showing they were epithelial cells, these constituted only 10% of the cell population. Under transmission electron microscopy, 90% of the cells demonstrated phenotypic characteristics of smooth muscle cells, such as cytoplasmic filaments close to and parallel to the plasma membrane, dense bodies, and pinocytotic vesicles. In addition, cells had elongated nuclei with peripheral heterochromatin and substantial extracellular matrix. The cells were similar in appearance to mesangial cells seen in normal glomeruli (Table 1) .
Cellular Viability
Cell counts were identical before and after 5 days of serum-free medium, indicating no obvious cellular losses due to prolonged treatment with serum-free medium. When cell number was plotted against ODî n the MTT assay, all points fell on a straight line through the origin. Treatment of cells with up to 5 days of serum-free medium did not result in a significant deviation from the predicted line, indicating that the cells were no less viable than cells treated with serum plus insulin (data not shown).
FIGURE 2. fane/ A-Bar graph shows that in comparison to cells treated with serum-free medium, cells treated with serum +insulin had a significantly increased cell number per dish. In contrast, cell number was not significantly changed in response to angiotensin II (All), insulin, or All+insulin. Pretreatment with losartan (DuP 753) did not affect cell count significantly. Panel B: Bar graph shows that in comparison to cells treated with serum-free medium, cells treated with serum+insulin had a significantly increased [ 3 H]thymidine incorporation per 10 5 cells. In contrast, [ 3 H]thymidine incorporation per 10 s cells was not significantly increased in response to All, and cells pretreated with losartan showed the same response as All-treated cells. Treatment of cells with insulin alone and All+insulin also significantly increased tritiated thymidine incorporation. Panel C: Bar graph shows that in comparison to cells treated with serum-free medium, cells treated with serum+insulin had a significantly
Assays of Angiotensins in Cell Media
Ang II was not rapidly degraded in our culture system in serum-free medium, at 4 hours, 80% of the added Ang II was detectable. Most of the degradation occurred within the first 2 hours and then appeared to level off (Figure 1 ). The major degradation product was angiotensin III (data not shown).
Cell Count
In comparison to cells grown in serum-free medium (Figure 2A) , treatment with serum plus insulin for 48 hours significantly increased the cell count (1.93±0.1 times control,p<0.05). In contrast, there was no significant change in cell number in response to Ang II (0.84±0.01 times control, /? = NS), insulin alone (1.13±0.07 times control, p=NS), or Ang II plus insulin (1.11 ±0.07 times control, p=NS). Pretreatment with losartan did not significantly alter the response of Ang II(1.06±0.11,p=NS).
Tritiated Thymidine Incorporation
Treatment with serum plus insulin, insulin alone, and Ang II plus insulin ( Figure 2B) 
Tritiated Leucine Incorporation
In comparison to serum-free medium ( Figure 2C) 
Total Protein Content
In comparison to serum-free medium ( Figure 2D ), cells treated with serum plus insulin, insulin alone, and Ang II plus insulin demonstrated a significant increase in total protein content (1.65±0.07 times control, p<0.05; 1.93±0.23 times control, p<0.05; 2.18±0.18 times control, p<0.05, respectively). Cells treated with Ang II also showed a significant, though lesser, increase in total protein content. This increase was dose dependent, with the greatest increase occurring in response to 10~6 M Ang n (1.38±0.04 times control, p<0.05). Pretreatment with losartan significantly reduced the increase in total protein content per 10 s cells to 1.06±0.13 times control (an 84% decrease).
CeU Size
Treatment with serum plus insulin increased cell size by approximately 18%, as demonstrated by fluorescence-activated cell sorting. Treatment with Ang II (10~6 M) increased cell size by approximately 7% (Figure 3) .
Discussion
Ang II is a potentially important factor in the development of glomerulosclerosis. Angiotensin converting enzyme inhibitors, which block Ang II generation, have been demonstrated to decrease proteinuria in hypertensive and normotensive humans with diabetic nephropathy 14 -15 and to prevent the development or progression of morphological changes in animal models of glomerulosclerosis. 4 -5 Ang II may adversely affect the glomerular filtration barrier, probably by altering concentrations of proteogfycans (specifically, heparan sulfate) in the glomerular basement membrane. This alters its charge, which alters, in turn, its protein-sieving characteristics. 16 - 17 A separate hemodynamic effect of Ang II is to increase intraglomerular pressure, which can also cause proteinuria and lead to glomerulosclerosis. 18 Because the protective effects of angiotensin converting enzyme inhibitors may also occur in animal models of glomerulosclerosis, which are not associated with ele- vated intraglomerular pressure, 5 amelioration of intraglomerular hypertension alone does not completely explain the effects seen with angiotensin converting enzyme inhibitors. These observations suggest that Ang II acts directly to enhance mesangial volume. Ang II has been demonstrated to enhance the production of type I collagen in SV-40 transformed mesangial cells 8 and to increase mesangial uptake of macromolecules 19 ; these are two mechanisms by which mesangial volume could potentially increase. The effects of Ang II on mesangial cell growth, however, have been conflicting*-8 but are likely dependent on the state of differentiation of the cell and the presence of serum.
The current study demonstrates that under the specific conditions described, Ang II had no effect on [ 3 H]thymidine incorporation and cell count (hyperplasia) in cultured adult murine mesangial cells, whereas fHJleucine incorporation and total cellular protein content was significantly increased (hypertrophy) in response to Ang II. The murine mesangial cells maintained a consistent phenotype at the passages used (passages 4 to 6), with 90% demonstrating myofibrils and positive immunostaining for muscle proteins. The failure of Ang II to induce hyperplasia in cultured cells was not due to growth arrest, because after 48 hours in serum-free conditions, the mesangial cells were capable of responding appropriately to a mitogenic stimulus (serum plus insulin). Also, decreased viability of cells held for 5 days in serum-free medium was not the cause, because there was no significant change in cell counts before and after serum-free medium and no significant decrease in viability noted by MTT assay. The hypertrophic response to Ang II was confirmed by direct examination of cell size by fluorescence-activated cell sorting, which demonstrated a 7% increase in cell size. The lack of a more impressive increase in cell size using this technique may be due to the fact that Ang II causes mesangial cell contraction, 19 which may artifactuaUy reduce cell size. In addition, significant amounts of protein synthesized by the mesangial cell may have been exported from the cell (i.e., into the matrix).
The effect of Ang II on hypertrophy was dose related and was partially inhibited by losartan, an Ang II subtype 1 (AT,) receptor antagonist. Previous investigations in rat mesangial cells have demonstrated that approximately 70% of the Ang II receptors are type I. 20 Our finding that losartan blocked 56% of the Ang Il-induced increase in [ 3 H]leucine incorporation and 84% of the Ang Il-induced increase in total protein content is consistent with this data and demonstrates that this direct effect of Ang II on the mesangial cell is mediated through the AT( receptor. This receptor mediates most of the vascular, adrenal, and renal proximal tubular actions of Ang II. 21 A physiological function of the Ang II subtype 2 receptor is unknown, but it is abundant in the fetus and, thus, has been implicated in growth and differentiation. 22 Under certain conditions, Ang II may have a proliferative effect on mesangial cells. In cultures of fetal human mesangial cells 7 or SV-40 transformed murine mesangial cells, 8 Ang II was shown to be mitogenic. Fetal cells may have intrinsically different growth properties from adult cells, and SV-40 transformation is likely to alter a cell's response to a growth stimulus. In other studies performed in primary cultures of adult human and rat mesangial cells, Ang II did not induce mitogenesis. 6 In some of these studies, an increase in tritiated thymidine incorporation was equated with an increase in cell number. However, as can be seen in our results, DNA synthesis does not necessarily imply proliferation. Insulin caused an increase in tritiated thymidine incorporation without passage through mitosis. The increase in cellular DNA without an increase in cell number results in polyploidy, which also occurs in vascular smooth muscle cells treated with Ang II in serum-free medium. 23 In our culture system, insulin was capable of causing a significant increase in cell number only in the presence of 0.4% fetal calf serum (data not shown), suggesting that while insulin alone could stimulate DNA synthesis, more than one factor is needed to induce mitosis in these cells.
In cultured adult rat vascular smooth muscle cells, Ang II has been reported to cause hypertrophy but not hyperplasia. 23 The Ang II concentration used to effect hypertrophy in vascular smooth muscle cells was similar to that used to cause hypertrophy in mesangial cells, i.e., 10" 6 M. In vascular smooth muscle cells, Ang II increases c-fos, 2 * c-myc, 75 c-jun, and c-jun-B protooncogene expression. 26 Ang II also stimulates a dual system in which there is an increase in platelet-derived growth factor messenger RNA, which stimulates cell growth, 25 and transforming growth factor-/3, which slows cell growth. 27 Thus, the ultimate effect of Ang II on vascular smooth muscle cell growth may be the sum of stimulatory and inhibitory factors. 28 In such a system, inhibitory factors may allow hypertrophy and prevent proliferation. On the other hand, hypertrophy, but not hyperplasia, may be an extended state of differentiation associated with enhancement of specific functions, such as contraction and extracellular matrix production. Ang II has also been demonstrated to cause hypertrophy but not hyperplasia in cultured murine proximal tubular cells. 29 This response was associated with the induction of the cellular oncogenes c-fos, c-myc, and c-n-ras and was mediated by a pertussis toxin-sensitive G protein.
Ang II enhances specific functions in proximal tubular cells, including sodium and bicarbonate reabsorption. 30 - 31 In contrast to vascular smooth muscle cells of normal animals, in cultures of vascular smooth muscle cells from the adult spontaneously hypertensive rat, Ang II induces mitosis. 32 Thus, both the stimulus and intrinsic cellular factors may determine whether the growth response is hypertrophic or hyperplastic.
The present studies suggest that Ang II is a competence factor for cultured adult murine mesangial cells, whereas insulin is a progression factor. Both hormones stimulated protein synthesis, but only insulin allowed cells to enter the S phase of the cell cycle. The effects of Ang II and insulin were not additive. Both insulin and insulin-like growth factor 1 are known progression factors. 33 In studies of human adult cultured mesangial cells, platelet-derived growth factor was demonstrated to be a competence factor, whereas insulin-like growth factor 1 was identified as a progression factor. 9 Cell number was not reported. Whether other factors in serum are necessary for mesangial cell division remains to be determined. Nevertheless, these results allow us to define conditions in which cultured mesangial cells can be investigated in different phases of the cell cycle. This approach will ultimately be important to understanding the mechanisms of cellular growth of mesangial cells and to dissecting specific effects of factors potentially involved in the glomerulosclerotic process.
